These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 27775940

  • 1. Prognostic Value of FDG Uptake of Portal Vein Tumor Thrombosis in Patients With Locally Advanced Hepatocellular Carcinoma.
    Lee JW, Hwang SH, Kim DY, Han KH, Yun M.
    Clin Nucl Med; 2017 Jan; 42(1):e35-e40. PubMed ID: 27775940
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prognostic Significance of ¹⁸F-FDG Uptake in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization or Concurrent Chemoradiotherapy: A Multicenter Retrospective Cohort Study.
    Lee JW, Oh JK, Chung YA, Na SJ, Hyun SH, Hong IK, Eo JS, Song BI, Kim TS, Kim DY, Kim SU, Moon DH, Lee JD, Yun M.
    J Nucl Med; 2016 Apr; 57(4):509-16. PubMed ID: 26742711
    [Abstract] [Full Text] [Related]

  • 4. 18F-FDG PET/CT Can Predict Survival of Advanced Hepatocellular Carcinoma Patients: A Multicenter Retrospective Cohort Study.
    Na SJ, Oh JK, Hyun SH, Lee JW, Hong IK, Song BI, Kim TS, Eo JS, Lee SW, Yoo IR, Chung YA, Yun M.
    J Nucl Med; 2017 May; 58(5):730-736. PubMed ID: 27789714
    [Abstract] [Full Text] [Related]

  • 5. Value of 18F-FDG PET/CT in the diagnosis of portal vein tumor thrombus in patients with hepatocellular carcinoma.
    Wu B, Zhang Y, Tan H, Shi H.
    Abdom Radiol (NY); 2019 Jul; 44(7):2430-2435. PubMed ID: 30944961
    [Abstract] [Full Text] [Related]

  • 6. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
    Lee JM, Jang BK, Lee YJ, Choi WY, Choi SM, Chung WJ, Hwang JS, Kang KJ, Kim YH, Chauhan AK, Park SY, Tak WY, Kweon YO, Kim BS, Lee CH.
    Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
    [Abstract] [Full Text] [Related]

  • 7. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
    Luo J, Zheng JP, Shao GL, Wen S, Guo LW, Zeng H, Zhang L, Qian CY, Hao WY.
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr 20; 26(4):298-304. PubMed ID: 29996343
    [Abstract] [Full Text] [Related]

  • 8. Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score-Matched Analysis.
    Liu BJ, Gao S, Zhu X, Guo JH, Kou FX, Liu SX, Zhang X, Wang XD, Cao G, Chen H, Liu P, Zhu LZ, Xu HF, Yang RJ.
    Biomed Res Int; 2021 Apr 20; 2021():6670367. PubMed ID: 34337041
    [Abstract] [Full Text] [Related]

  • 9. Prognosis of hepatocellular carcinoma with portal vein tumor thrombus:assessment based on clinical and computer tomography characteristics.
    Jia L, Kiryu S, Watadani T, Akai H, Yamashita H, Akahane M, Ohtomo K.
    Acta Med Okayama; 2012 Apr 20; 66(2):131-41. PubMed ID: 22525471
    [Abstract] [Full Text] [Related]

  • 10. 18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma.
    Kim BK, Kang WJ, Kim JK, Seong J, Park JY, Kim DY, Ahn SH, Lee DY, Lee KH, Lee JD, Han KH.
    Cancer; 2011 Oct 15; 117(20):4779-87. PubMed ID: 21469082
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with Barcelona Clinic Liver Cancer stages 0 and A hepatocellular carcinomas: a multicenter retrospective cohort study.
    Hyun SH, Eo JS, Lee JW, Choi JY, Lee KH, Na SJ, Hong IK, Oh JK, Chung YA, Song BI, Kim TS, Kim KS, Moon DH, Yun M.
    Eur J Nucl Med Mol Imaging; 2016 Aug 15; 43(9):1638-45. PubMed ID: 26936852
    [Abstract] [Full Text] [Related]

  • 12. Prognostic implication of (18)F FDG-PET in patients with extrahepatic metastatic hepatocellular carcinoma undergoing systemic treatment, a retrospective cohort study.
    Shin DY, Han SW, Oh DY, Im SA, Kim TY, Bang YJ.
    Cancer Chemother Pharmacol; 2011 Jul 15; 68(1):165-75. PubMed ID: 20872146
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Alpha-fetoprotein and 18F-FDG standard uptake value predict tumor recurrence after liver transplantation for hepatocellular carcinoma with portal vein tumor thrombosis: Preliminary experience.
    Yang Z, Luo FZ, Wang S, Lerut J, Zhuang L, Li QY, Xu X, Zheng SS.
    Hepatobiliary Pancreat Dis Int; 2020 Jun 15; 19(3):229-234. PubMed ID: 32303439
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chemoembolisation with polyvinyl alcohol for advanced hepatocellular carcinoma with portal vein tumour thrombosis and arterioportal shunts: efficacy and prognostic factors.
    Xiao L, Liu Q, Zhao W, Pang H, Zeng Q, Chen Y, Zhao J, Mei Q, He X.
    Clin Radiol; 2018 Dec 15; 73(12):1056.e17-1056.e22. PubMed ID: 30224186
    [Abstract] [Full Text] [Related]

  • 17. 18F-FDG PET/CT predicts survival after 90Y transarterial radioembolization in unresectable hepatocellular carcinoma.
    Jreige M, Mitsakis P, Van Der Gucht A, Pomoni A, Silva-Monteiro M, Gnesin S, Boubaker A, Nicod-Lalonde M, Duran R, Prior JO, Denys A, Schaefer N.
    Eur J Nucl Med Mol Imaging; 2017 Jul 15; 44(7):1215-1222. PubMed ID: 28233086
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Thrombocytopenia: A prognostic factor for hepatocellular carcinoma patients with portal vein tumor thrombus after hepatectomy.
    Cheng YQ, Wang K, Zhang XP, Wei XB, Jiang YB, Hu YR, Mao FF, Guo WX, Shi J, Cheng SQ.
    J Gastroenterol Hepatol; 2019 Jul 15; 34(7):1214-1221. PubMed ID: 30402968
    [Abstract] [Full Text] [Related]

  • 20. Comparison of chemoembolization with and without radiation therapy and sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis.
    Kim GA, Shim JH, Yoon SM, Jung J, Kim JH, Ryu MH, Ryoo BY, Kang YK, Lee D, Kim KM, Lim YS, Lee HC, Chung YH, Lee YS.
    J Vasc Interv Radiol; 2015 Mar 15; 26(3):320-9.e6. PubMed ID: 25612807
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.